Telos Gains on Navy Contract
Telos Corporation (NASDAQ: TLS) watched its shares reach into the green Wednesday, as the leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations today announced its on-ramp as a prime contractor to the U.S. Navy – SeaPort Next Generation (SeaPort NxG) multiple award, indefinite-delivery/indefinite-quantity (IDIQ) contract.SeaPort NxG serves the Navy Virtual SYSCOM Commanders, including NAVAIR, NAVFAC, NAVSEA, NAVSUP, NAVWAR and ONR, as well as the Military Sealift Command (MSC) and the United States Marine Corps (USMC). SeaPort NxG is the U.S. Navy’s integrated and mandatory approach to contracting for professional support services (PSS). As a prime contractor, Telos will be eligible to bid on task orders until 2028, at which time the Navy will perform a re-compete for a nine-year period of performance.“Telos is pleased to be a part of SeaPort NxG, which strengthens our relationship with the U.S. Navy,” said John B. Wood, CEO and chairman, Telos. “We look forward to providing the Navy with network engineering and operational support, program management, logistics, and training to support cyber risk assessment.”In addition to SeaPort NxG, since 2023, Telos has won positions on the following federal government blanket purchase agreement (BPA) and IDIQ contract vehicles, which, when combined with SeaPort NxG, provide market access to compete for new business opportunities that, in the aggregate, represent approximately a $35 billion addressable market. TLS shares captured nine cents, or 2.9%, to $3.34.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


